These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Long-term twice-daily oral acyclovir therapy suppresses frequently recurrent genital herpes.
    Author: Molin L, Bäck O, Frödin T, Svennerholm B.
    Journal: Scand J Infect Dis; 1987; 19(2):273-4. PubMed ID: 3616492.
    Abstract:
    The efficacy of oral acyclovir in a twice-daily treatment regime was demonstrated in an open long-term study in 8 patients with frequently relapsing genital herpes type II infections. The treatment was well tolerated and no side effects were noted during the medication period of 6-21 months. No signs of decreased sensitivity for acyclovir appeared.
    [Abstract] [Full Text] [Related] [New Search]